Lynch & Associates IN Has $2.36 Million Holdings in Colgate-Palmolive (NYSE:CL)

Lynch & Associates IN decreased its position in Colgate-Palmolive (NYSE:CL) by 2.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,566 shares of the company’s stock after selling 610 shares during the period. Lynch & Associates IN’s holdings in Colgate-Palmolive were worth $2,355,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Tucker Asset Management LLC bought a new stake in Colgate-Palmolive during the first quarter worth about $27,000. Register Financial Advisors LLC bought a new position in shares of Colgate-Palmolive in the first quarter valued at about $30,000. Kepos Capital LP acquired a new position in Colgate-Palmolive during the 4th quarter worth about $40,000. Carmel Capital Partners LLC acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $42,000. Finally, Newbridge Financial Services Group Inc. raised its stake in shares of Colgate-Palmolive by 108.7% in the first quarter. Newbridge Financial Services Group Inc. now owns 578 shares of the company’s stock worth $43,000 after acquiring an additional 301 shares during the last quarter. 78.36% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider John W. Kooyman sold 21,677 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the transaction, the insider now owns 6,384 shares in the company, valued at $495,972.96. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider John W. Kooyman sold 21,677 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the completion of the sale, the insider now directly owns 6,384 shares of the company’s stock, valued at approximately $495,972.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Gregory Malcolm sold 10,493 shares of the business’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $73.90, for a total value of $775,432.70. Following the transaction, the vice president now owns 7,852 shares of the company’s stock, valued at approximately $580,262.80. The disclosure for this sale can be found here. Insiders sold 105,501 shares of company stock worth $7,838,332 over the last three months. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Down 1.1 %

Shares of CL stock traded down $0.79 during trading hours on Tuesday, hitting $73.06. 1,267,788 shares of the company were exchanged, compared to its average volume of 4,668,396. The firm has a market cap of $60.40 billion, a P/E ratio of 41.03, a P/E/G ratio of 3.11 and a beta of 0.50. The company has a 50 day simple moving average of $75.06 and a two-hundred day simple moving average of $75.85. The company has a debt-to-equity ratio of 28.43, a quick ratio of 0.73 and a current ratio of 1.17. Colgate-Palmolive has a fifty-two week low of $67.84 and a fifty-two week high of $82.09.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 28th. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.02. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 8.02%. The business had revenue of $4.82 billion during the quarter, compared to the consensus estimate of $4.70 billion. During the same period last year, the business posted $0.72 earnings per share. The business’s revenue for the quarter was up 7.5% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive will post 3.17 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 106.67%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Barclays upped their target price on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 1st. Royal Bank of Canada reiterated a “sector perform” rating and issued a $83.00 price objective on shares of Colgate-Palmolive in a report on Monday, July 31st. Deutsche Bank Aktiengesellschaft boosted their target price on Colgate-Palmolive from $88.00 to $91.00 and gave the stock a “buy” rating in a research report on Monday, July 31st. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Monday, September 11th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $85.33.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.